Profile | GDS5420 / 243580_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 90.27 | 40 |
GSM1296119 | B_lesional_pre-dose | 139.86 | 46 |
GSM1296076 | C_lesional_pre-dose | 47.31 | 30 |
GSM1296092 | D_lesional_pre-dose | 66.31 | 38 |
GSM1296103 | E_lesional_pre-dose | 49.5 | 31 |
GSM1296078 | F_lesional_pre-dose | 87.94 | 41 |
GSM1296107 | G_lesional_pre-dose | 98.4 | 39 |
GSM1296109 | H_lesional_pre-dose | 61.81 | 32 |
GSM1296080 | I_lesional_pre-dose | 209.95 | 54 |
GSM1296090 | J_lesional_pre-dose | 98.99 | 43 |
GSM1296074 | K_lesional_pre-dose | 58 | 35 |
GSM1296111 | L_lesional_pre-dose | 99.77 | 39 |
GSM1296099 | M_lesional_pre-dose | 75.96 | 37 |
GSM1296086 | O_lesional_pre-dose | 122.56 | 46 |
GSM1296117 | P_lesional_pre-dose | 66.92 | 32 |
GSM1296113 | Q_lesional_pre-dose | 106.48 | 39 |
GSM1296096 | R_lesional_pre-dose | 90 | 40 |
GSM1296105 | S_lesional_pre-dose | 125.5 | 44 |
GSM1296098 | T_lesional_pre-dose | 82.35 | 37 |
GSM1296101 | U_lesional_pre-dose | 93.47 | 40 |
GSM1296121 | V_lesional_pre-dose | 92.93 | 39 |
GSM1296088 | W_lesional_pre-dose | 99.96 | 42 |
GSM1296082 | X_lesional_pre-dose | 83.24 | 40 |
GSM1296115 | Y_lesional_pre-dose | 123.49 | 44 |
GSM1296084 | Z_lesional_pre-dose | 100.93 | 41 |
GSM1296072 | B_lesional_day8 | 148.15 | 46 |
GSM1296069 | L_lesional_day8 | 114.68 | 41 |
GSM1296071 | P_lesional_day8 | 117.91 | 41 |
GSM1296070 | Y_lesional_day8 | 93.66 | 37 |
GSM1296073 | V_lesional_day8 | 62.83 | 33 |
GSM1296034 | A_lesional_day15 | 58.71 | 32 |
GSM1296041 | G_lesional_day15 | 61.9 | 32 |
GSM1296035 | R_lesional_day15 | 128.57 | 46 |
GSM1296038 | U_lesional_day15 | 106.61 | 43 |
GSM1296047 | B_lesional_day15 | 169.04 | 48 |
GSM1296039 | E_lesional_day15 | 139.17 | 47 |
GSM1296042 | H_lesional_day15 | 108.99 | 40 |
GSM1296043 | L_lesional_day15 | 97.21 | 38 |
GSM1296037 | M_lesional_day15 | 112.25 | 42 |
GSM1296046 | P_lesional_day15 | 126.68 | 43 |
GSM1296044 | Q_lesional_day15 | 87.7 | 36 |
GSM1296045 | Y_lesional_day15 | 84.23 | 35 |
GSM1296025 | C_lesional_day15 | 89.48 | 40 |
GSM1296033 | D_lesional_day15 | 101.62 | 42 |
GSM1296027 | I_lesional_day15 | 172.82 | 52 |
GSM1296032 | J_lesional_day15 | 126.03 | 45 |
GSM1296024 | K_lesional_day15 | 80.85 | 39 |
GSM1296031 | W_lesional_day15 | 103.93 | 41 |
GSM1296028 | X_lesional_day15 | 115.13 | 44 |
GSM1296029 | Z_lesional_day15 | 130.09 | 46 |
GSM1296026 | F_lesional_day15 | 117.84 | 45 |
GSM1296030 | O_lesional_day15 | 130.1 | 48 |
GSM1296040 | S_lesional_day15 | 174.82 | 50 |
GSM1296036 | T_lesional_day15 | 81.71 | 37 |
GSM1296048 | V_lesional_day15 | 60.15 | 32 |
GSM1296059 | A_lesional_day43 | 56.59 | 34 |
GSM1296066 | G_lesional_day43 | 103.16 | 40 |
GSM1296060 | R_lesional_day43 | 115.41 | 44 |
GSM1296063 | U_lesional_day43 | 71.91 | 36 |
GSM1296064 | E_lesional_day43 | 116.83 | 44 |
GSM1296067 | H_lesional_day43 | 112.66 | 41 |
GSM1296062 | M_lesional_day43 | 136.44 | 46 |
GSM1296068 | Q_lesional_day43 | 72.44 | 32 |
GSM1296050 | C_lesional_day43 | 93.38 | 40 |
GSM1296057 | D_lesional_day43 | 134.3 | 46 |
GSM1296052 | I_lesional_day43 | 317.97 | 61 |
GSM1296054 | J_lesional_day43 | 119.04 | 44 |
GSM1296049 | K_lesional_day43 | 107.01 | 43 |
GSM1296055 | W_lesional_day43 | 122.06 | 43 |
GSM1296053 | X_lesional_day43 | 305.31 | 59 |
GSM1296058 | Z_lesional_day43 | 140.16 | 47 |
GSM1296051 | F_lesional_day43 | 122.43 | 46 |
GSM1296056 | O_lesional_day43 | 120.48 | 46 |
GSM1296065 | S_lesional_day43 | 82.37 | 38 |
GSM1296061 | T_lesional_day43 | 82.97 | 38 |
GSM1296095 | A_non-lesional_pre-dose | 60.41 | 34 |
GSM1296120 | B_non-lesional_pre-dose | 192.81 | 51 |
GSM1296077 | C_non-lesional_pre-dose | 60.38 | 35 |
GSM1296093 | D_non-lesional_pre-dose | 76.11 | 36 |
GSM1296104 | E_non-lesional_pre-dose | 126.1 | 45 |
GSM1296079 | F_non-lesional_pre-dose | 108.09 | 43 |
GSM1296108 | G_non-lesional_pre-dose | 135.97 | 45 |
GSM1296110 | H_non-lesional_pre-dose | 85.17 | 36 |
GSM1296081 | I_non-lesional_pre-dose | 137.79 | 48 |
GSM1296091 | J_non-lesional_pre-dose | 114.99 | 45 |
GSM1296075 | K_non-lesional_pre-dose | 47.83 | 31 |
GSM1296112 | L_non-lesional_pre-dose | 159.72 | 46 |
GSM1296100 | M_non-lesional_pre-dose | 135.63 | 45 |
GSM1296087 | O_non-lesional_pre-dose | 259.27 | 58 |
GSM1296118 | P_non-lesional_pre-dose | 95.71 | 38 |
GSM1296114 | Q_non-lesional_pre-dose | 148.7 | 45 |
GSM1296097 | R_non-lesional_pre-dose | 160.53 | 49 |
GSM1296106 | S_non-lesional_pre-dose | 89.24 | 38 |
GSM1296102 | U_non-lesional_pre-dose | 90.86 | 39 |
GSM1296122 | V_non-lesional_pre-dose | 147.2 | 46 |
GSM1296089 | W_non-lesional_pre-dose | 203.13 | 52 |
GSM1296083 | X_non-lesional_pre-dose | 323.18 | 60 |
GSM1296116 | Y_non-lesional_pre-dose | 128.66 | 42 |
GSM1296085 | Z_non-lesional_pre-dose | 289.19 | 58 |